US 11,684,567 B2
Compositions and methods for treating an infection
Jay Richard Ray, II, Conroe, TX (US)
Assigned to CMPD Licensing, LLC, Conroe, TX (US)
Filed by CMPD Licensing, LLC, Conroe, TX (US)
Filed on Apr. 25, 2019, as Appl. No. 16/394,937.
Application 16/394,937 is a continuation in part of application No. 16/270,335, filed on Feb. 7, 2019.
Application 16/270,335 is a continuation in part of application No. 15/881,009, filed on Jan. 26, 2018, granted, now 10,898,491.
Application 16/270,335 is a continuation in part of application No. 15/976,579, filed on May 10, 2018, granted, now 11,278,590.
Application 15/976,579 is a continuation in part of application No. 14/990,168, filed on Jan. 7, 2016, granted, now 10,898,455.
Application 14/990,168 is a continuation in part of application No. 15/597,936, filed on May 17, 2017, granted, now 10,105,342, issued on Oct. 23, 2017.
Application 15/597,936 is a continuation in part of application No. 15/668,184, filed on Aug. 3, 2017.
Application 15/597,936 is a continuation in part of application No. 15/440,800, filed on Feb. 23, 2017, abandoned.
Application 15/440,800 is a continuation in part of application No. 14/975,172, filed on Dec. 18, 2015, granted, now 9,707,229, issued on Jul. 18, 2017.
Application 14/975,172 is a continuation in part of application No. 14/819,342, filed on Aug. 5, 2015, granted, now 10,973,804.
Application 15/881,009 is a continuation in part of application No. 15/625,989, filed on Jun. 16, 2017, abandoned.
Application 15/625,989 is a continuation in part of application No. 14/975,172, filed on Dec. 18, 2015, granted, now 9,707,229, issued on Jul. 18, 2017.
Application 14/975,172 is a continuation in part of application No. 15/440,800, filed on Feb. 23, 2017, abandoned.
Claims priority of provisional application 62/298,994, filed on Feb. 23, 2016.
Claims priority of provisional application 62/298,991, filed on Feb. 23, 2016.
Claims priority of provisional application 62/370,571, filed on Aug. 3, 2016.
Prior Publication US 2019/0247300 A1, Aug. 15, 2019
Int. Cl. A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/22 (2006.01); A61K 47/46 (2006.01); A61K 31/496 (2006.01); A61K 45/06 (2006.01); A61P 31/10 (2006.01); A61K 47/02 (2006.01)
CPC A61K 9/0014 (2013.01) [A61K 9/00 (2013.01); A61K 9/08 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/46 (2013.01); A61P 31/10 (2018.01); A61K 9/0031 (2013.01); A61K 9/0034 (2013.01)] 20 Claims
 
1. A method of treating a fungal infection of a subject, the method comprising:
formulating a topical treatment solution comprising combining itraconazole oral solution, 10 mg/mL, and a diluent, wherein the itraconazole oral solution, 10 mg/mL, includes propylene glycol and at least one of cherry flavor or caramel flavor; and
topically administering the topical treatment solution to the subject, wherein administering comprises contacting an infected mucosal surface of a vagina or anus of the subject, and wherein the topical treatment solution has a pH of 2.5 or less when administered.